New Summit data clouds approval pathway in lung cancer“A combination of ivonescimab and chemotherapy didn’t extend survival over chemo alone in a global trial, missing a key goal often emphasized by regulators.” First-in-human trial shows promising results for...
Cleveland Clinic Finds Most Men Say Exercise Positively Impacts Their Mental Health, Confidence, and Sex Drive, but Nearly 1 in 3 Still Skip It“Most men recognize that staying active improves their energy, mood, and sex drive, but a new Cleveland Clinic survey showed...
The quality of patient decision aids for lung cancer screening: Results from an environmental scan“Shared decision making is recommended for lung cancer screening (LCS) by professional organizations and payers. Patient decision aids can be used to support shared...
Study reveals beneficial effects of diet and exercise on alcohol-related adverse liver health“Research in the Journal of Hepatology shows that assessing the moderating effects of two important lifestyle behaviors on liver mortality risk offers a more complete and...
Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer“SAN FRANCISCO and SUZHOU, China, Aug. 24, 2025 /PRNewswire/ — Innovent Biologics, Inc....
More News and Updates